In vivo studies demonstrated that gomisin attenuates hyperglycemia induced by a high-fat diet, insulin resistance, and endoplasmic reticulum (ER) stress by inhibiting CB1R signaling and ceramide biosynthesis 20. The gene discussed is CNR1; the disease is Insulin resistance.